Reuters logo
BRIEF-‍Argos doses first HIV patient with AGS-004
September 6, 2017 / 12:20 PM / 3 months ago

BRIEF-‍Argos doses first HIV patient with AGS-004

Sept 6 (Reuters) - Argos Therapeutics Inc

* ‍Argos announces first dosing of HIV patient with AGS-004 derived from latent viral reservoir​

* Argos Therapeutics Inc - ‍in ongoing phase 2 eradication trial, ags-004 has continued to be well tolerated to date​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below